Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+922K
-
Total reported value, excl. options
-
$757M
-
Value change
-
+$26.6M
-
Number of buys
-
52
-
Number of sells
-
-22
-
Price
-
$26.64
Significant Holders of ArriVent BioPharma, Inc. - Common Stock (AVBP) as of Q4 2024
92 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock as of Q4 2024.
ArriVent BioPharma, Inc. - Common Stock (AVBP) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 41M outstanding shares and own 69.49% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4.48M shares), ORBIMED ADVISORS LLC (3.03M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.25M shares), BlackRock, Inc. (2.14M shares), FMR LLC (2.1M shares), Octagon Capital Advisors LP (2.06M shares), Sofinnova Investments, Inc. (1.7M shares), INFINITUM ASSET MANAGEMENT, LLC (1.64M shares), Novo Holdings A/S (1.52M shares), and General Catalyst Group Management, LLC (1.49M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.